atenolol has been researched along with Hypokalemia in 10 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cetamolol was able to block epinephrine-induced hypokalemia completely, in a dose-related manner, and to block isoproterenol-induced hypokalemia partially." | 5.28 | Comparison of the effects of cetamolol and atenolol on epinephrine- and isoproterenol-induced hypokalemia in anesthetized dogs. ( Klein, M; Nettler, S; Oshiro, G; Smith, T; Stupienski, RF, 1989) |
| " To determine whether thiazide-induced diabetes is mediated by changes in potassium, we analyzed data from 3790 nondiabetic participants in the Systolic Hypertension in Elderly Program, a randomized clinical trial of isolated systolic hypertension in individuals aged >or=60 years treated with chlorthalidone or placebo." | 5.13 | Changes in serum potassium mediate thiazide-induced diabetes. ( Appel, LJ; Klag, MJ; Miller, ER; Parekh, RS; Shafi, T, 2008) |
| "Cetamolol was able to block epinephrine-induced hypokalemia completely, in a dose-related manner, and to block isoproterenol-induced hypokalemia partially." | 1.28 | Comparison of the effects of cetamolol and atenolol on epinephrine- and isoproterenol-induced hypokalemia in anesthetized dogs. ( Klein, M; Nettler, S; Oshiro, G; Smith, T; Stupienski, RF, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tachamo, N | 1 |
| Lohani, S | 1 |
| Nazir, S | 1 |
| Juliano, N | 1 |
| Shafi, T | 1 |
| Appel, LJ | 1 |
| Miller, ER | 1 |
| Klag, MJ | 1 |
| Parekh, RS | 1 |
| Okin, PM | 1 |
| Kjeldsen, SE | 1 |
| Lindholm, LH | 1 |
| Dahlöf, B | 1 |
| Devereux, RB | 1 |
| Struthers, AD | 2 |
| Reid, JL | 2 |
| Whitesmith, R | 1 |
| Rodger, JC | 1 |
| Kharasch, ED | 1 |
| Bowdle, TA | 1 |
| Klein, M | 1 |
| Stupienski, RF | 1 |
| Nettler, S | 1 |
| Smith, T | 1 |
| Oshiro, G | 1 |
| Forfang, K | 1 |
| Simonsen, S | 1 |
| Smith, M | 1 |
| Drake, HF | 1 |
| Corfield, DR | 1 |
| Treasure, T | 1 |
| Odugbesan, O | 1 |
| Chesner, IM | 1 |
| Bailey, G | 1 |
| Barnett, AH | 1 |
| Whyte, KF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Triple-Blind, Parallel Study to Investigate the Effect of Losartan Versus Atenolol on the Reduction of Morbidity and Mortality in Hypertensive Patients With Left Ventricular Hypertrophy[NCT00338260] | Phase 3 | 496 participants (Actual) | Interventional | 1995-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for atenolol and Hypokalemia
| Article | Year |
|---|---|
Changes in serum potassium mediate thiazide-induced diabetes.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Diabetes Mellitus, Type 2; | 2008 |
The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Double-Blind Method; Female; Humans; Hyd | 2012 |
The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man.
Topics: Adult; Atenolol; Blood Pressure; Epinephrine; Heart Rate; Humans; Hypokalemia; Male; Myocardial Infa | 1983 |
Hypokalemia before induction of anesthesia and prevention by beta 2 adrenoceptor antagonism.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anesthesia; Atenolol; Humans; Hypokalemia; Int | 1991 |
Effects of atenolol and pindolol on the hypokalaemic and cardiovascular responses to adrenaline infusion.
Topics: Adult; Atenolol; Blood Pressure; Electrolytes; Epinephrine; Female; Heart Rate; Hemodynamics; Humans | 1989 |
Epinephrine-induced hypokalemia: the role of beta adrenoceptors.
Topics: Adult; Atenolol; Blood Pressure; Electrocardiography; Epinephrine; Heart Rate; Humans; Hypokalemia; | 1986 |
4 other studies available for atenolol and Hypokalemia
| Article | Year |
|---|---|
Paralysis that easily reverses: a case of thyrotoxic periodic paralysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Antithyroid Agents; Atenolol; Humans; Hypokalemia; Hy | 2017 |
Comparison of the effects of cetamolol and atenolol on epinephrine- and isoproterenol-induced hypokalemia in anesthetized dogs.
Topics: Acetamides; Adrenergic beta-Antagonists; Anesthesia; Animals; Atenolol; Dogs; Dose-Response Relation | 1989 |
The effects of beta blockade on dopamine and dobutamine induced hypokalaemia in dogs.
Topics: Animals; Atenolol; Blood Pressure; Dobutamine; Dogs; Dopamine; Heart Rate; Hypokalemia; Infusions, I | 1989 |
Hazards of combined beta-blocker/diuretic tablets.
Topics: Antihypertensive Agents; Atenolol; Chlorthalidone; Drug Combinations; Female; Humans; Hypokalemia; M | 1985 |